Coronado Biosciences Inc $1.62

down -0.01


28/7/2014 10:22 AM  |  NASDAQ : CNDO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CNDO Trend Analysis - it has underperformed the S&P 500 by 97%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Coronado Releases Interim Data; Says Final Results of Study Expected Mid ...

    Benzinga
  3. Coronado Biosciences Announces Independent Data Monitoring Committee Recommends ...

    Benzinga
  4. UPDATE: Canaccord Genuity Downgrades Coronado Biosciences Following TRUST-1 ...

    Benzinga
  5. TheStreetSweeper Says Warned Investors about Coronado Biosciences Months ...

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. UPDATE: Coronado Says Top-Line Results from Trust-I Phase 2 Trial of TSO ...

    Benzinga
  8. Coronado Reports Initiation of Phase 2 Study Evaluating TSO in Ulcerative ...

    Benzinga
  9. Weekly CFO Buys Highlight

    GuruFocus
  10. Weekly CEO Buys Highlight: CNDO

    GuruFocus
  11. Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K

    GuruFocus
  12. Coronado Biosciences Inc (CNDO) CEO Harlan F Weisman buys 20,000 Shares

    GuruFocus
  13. UPDATE: Wedbush Securities Initiates Coronado Biosciences at Outperform ...

    Benzinga
  14. Coronado Biosciences Inc. (CNDO) CEO Bobby W Phd Sandage buys 3,811 Shares

    GuruFocus
  15. Coronado Biosciences Inc (CNDO) CEO Bobby W Phd Sandage buys 3,811 Shares

    GuruFocus
  16. Coronado Initiates Phase 1/2 Dose Escalation Trial of Allogeneic Natural ...

    Benzinga
  17. Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO

    GuruFocus
  18. Coronado Biosciences Announces Closing of $28.8 Million Public Offering

    Benzinga
  19. Coronado Biosciences Announces the Pricing of Public Offering of 5M Shares ...

    Benzinga
  20. Coronado Biosciences Receives Orphan-Drug Designation From FDA for CNDO-1 ...

    Benzinga
  21. Financial Breakfast: Morning News Summary for June 8, 2012

    Benzinga
  22. A Peek Into The Market Before The Trading Starts

    Benzinga
  23. Coronado Biosciences Receives Notice of Allowance for First U.S. Patent ...

    Benzinga
  24. Financial Breakfast: Morning News Summary for February 14, 2012

    Benzinga
  25. Coronado Biosciences Announces IND Submission for CNDO-109 for the Treatment ...

    Benzinga
  26. Coronado Biosciences Signs Binding Terms of Agreement to Enter Into Collaboration ...

    Benzinga
Trading Center